| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Human Complement C5 |
|---|
| Description | 678-751aa; Partial. MW: 24.27kD. Purity >90% as determined by SDS-PAGE. Activation of C5 by a C5 convertase initiates the spontaneous assembly of the late complent components, C5-C9, into the membrane attack complex. C5b has a transient binding site for C6. The C5b-C6 complex is the foundation upon which the lytic complex is assbled. Derived from proteolytic degradation of complent C5, C5 anaphylatoxin is a mediator of local inflammatory process. Binding to the receptor C5AR1 induces a variety o |
|---|
| Size | 0.01 mg (E-Coli), 0.05 mg (E-Coli), 0.01 mg (Mammalian-Cell), 0.1 mg (E-Coli), 0.02 mg (Mammalian-Cell) |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4] |
|---|
| Gene, Accession, CAS # | C5, Gene ID: 727, Accession: NP_001726.2 |
|---|
| Catalog # | MBS1103026 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human Complement C5 from MYBIOSOURCE INC. |
|---|
| Product Specific References | Complete cDNA sequence of human complement pro-C5. Evidence of truncated transcripts derived from a single copy gene.Haviland D.L., Haviland J.C., Fleischer D.T., Hunt A., Wetsel R.A.J. Immunol. 146:362-368(1991) SeattleSNPs variation discovery resource |
|---|
| 产品资料 |
|
|